cilostazol has been researched along with Carotid Stenosis in 21 studies
Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the effects of cilostazol 200 mg, in addition to aspirin 100 mg and clopidogrel 75 mg, on carotid intima-media thickness (IMT) progression during a 2-year follow-up period in patients with acute coronary syndrome (ACS) requiring stent implantation." | 9.15 | Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. ( Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH, 2011) |
| " Diabetes mellitus and current smoker status were independent factors related to reactivity to clopidogrel." | 7.83 | Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures. ( Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S, 2016) |
| " We investigated the effects of cilostazol 200 mg, in addition to aspirin 100 mg and clopidogrel 75 mg, on carotid intima-media thickness (IMT) progression during a 2-year follow-up period in patients with acute coronary syndrome (ACS) requiring stent implantation." | 5.15 | Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. ( Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH, 2011) |
| "Cilostazol seems to decrease total ISR rates in patients undergoing CAS without affecting MI/stroke/death events, both in the early and late settings." | 4.93 | Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting. ( Aggeli, K; Filis, K; Galyfos, G; Geropapas, G; Sianou, A; Sigala, F, 2016) |
| " Diabetes mellitus and current smoker status were independent factors related to reactivity to clopidogrel." | 3.83 | Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures. ( Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S, 2016) |
| " We performed cognitive behavioral tests, including the water maze task, odor discrimination task, and novel object test; histological investigation of neuroinflammation, oligodendrocytes, myelin basic protein, and nodal or paranodal proteins at the nodes of Ranvier; and serial diffusion tensor imaging." | 3.83 | Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion. ( Back, DB; Choi, BR; Choi, DH; Han, JS; Han, SH; Kang, CH; Kim, BR; Kim, DH; Kim, HY; Kwon, KJ; Lee, J; Moon, WJ; Shin, CY, 2016) |
| "Bilateral common carotid artery stenosis (BCAS) mice were treated with oral administration of cilostazol or placebo starting from a week after the surgery." | 1.48 | Cilostazol alleviates white matter degeneration caused by chronic cerebral hypoperfusion in mice: Implication of its mechanism from gene expression analysis. ( Bannai, T; Iwata, A; Ohtomo, G; Ohtomo, R; Shindo, A; Tomimoto, H; Tsuji, S, 2018) |
| "A total of 949 patients with cervical carotid artery stenosis were enrolled at 43 institutions in Japan; 934 who had undergone CAS with antiplatelet drugs and followed for 1 year were analyzed." | 1.40 | Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting. ( Ezura, M; Hyodo, A; Matsubara, Y; Matsumaru, Y; Matsumoto, Y; Miyachi, S; Nakamura, M; Okada, Y; Sakai, C; Sakai, N; Terada, T; Yamagami, H; Yokoi, H, 2014) |
| "Cilostazol is a potent type III phosphodiesterase inhibitor, approved as an anti-platelet aggregation agent." | 1.35 | Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model. ( Hattori, N; Miyamoto, N; Mochizuki, H; Tanaka, R; Urabe, T; Zhang, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 17 (80.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohtomo, R | 1 |
| Bannai, T | 1 |
| Ohtomo, G | 1 |
| Shindo, A | 1 |
| Tomimoto, H | 1 |
| Tsuji, S | 1 |
| Iwata, A | 1 |
| Park, SY | 1 |
| Kim, HY | 2 |
| Lee, YS | 1 |
| Heo, HJ | 1 |
| Shin, HK | 1 |
| Lee, WS | 1 |
| Hong, KW | 1 |
| Kim, CD | 1 |
| Tsutsumi, M | 1 |
| Aikawa, H | 1 |
| Nii, K | 1 |
| Etou, H | 1 |
| Sakamoto, K | 1 |
| Kureshima, M | 1 |
| Inoue, R | 1 |
| Yoshida, H | 1 |
| Matsumoto, Y | 3 |
| Narita, S | 1 |
| Kazekawa, K | 1 |
| Tanaka, H | 1 |
| Zaima, N | 1 |
| Ito, H | 1 |
| Hattori, K | 1 |
| Yamamoto, N | 1 |
| Konno, H | 1 |
| Setou, M | 1 |
| Unno, N | 1 |
| Nakagawa, I | 3 |
| Wada, T | 3 |
| Park, HS | 3 |
| Nishimura, F | 1 |
| Yamada, S | 2 |
| Nakagawa, H | 1 |
| Kichikawa, K | 3 |
| Nakase, H | 3 |
| Fukuoka, T | 1 |
| Hayashi, T | 1 |
| Hirayama, M | 1 |
| Maruyama, H | 1 |
| Tanahashi, N | 1 |
| Sakai, N | 2 |
| Yamagami, H | 2 |
| Matsubara, Y | 1 |
| Ezura, M | 1 |
| Hyodo, A | 2 |
| Matsumaru, Y | 2 |
| Miyachi, S | 2 |
| Okada, Y | 1 |
| Terada, T | 1 |
| Yokoi, H | 1 |
| Nakamura, M | 1 |
| Sakai, C | 2 |
| Miyazaki, Y | 1 |
| Mori, T | 1 |
| Iwata, T | 1 |
| Aoyagi, Y | 1 |
| Tanno, Y | 1 |
| Kasakura, S | 1 |
| Yoshioka, K | 1 |
| Yokoyama, S | 2 |
| Hironaka, Y | 1 |
| Motoyama, Y | 2 |
| Takayama, K | 1 |
| Galyfos, G | 1 |
| Geropapas, G | 1 |
| Sigala, F | 1 |
| Aggeli, K | 1 |
| Sianou, A | 1 |
| Filis, K | 1 |
| Choi, BR | 1 |
| Kim, DH | 1 |
| Back, DB | 1 |
| Kang, CH | 1 |
| Moon, WJ | 1 |
| Han, JS | 1 |
| Choi, DH | 1 |
| Kwon, KJ | 1 |
| Shin, CY | 1 |
| Kim, BR | 1 |
| Lee, J | 1 |
| Han, SH | 1 |
| Zhang, N | 2 |
| Miyamoto, N | 2 |
| Tanaka, R | 2 |
| Mochizuki, H | 2 |
| Hattori, N | 2 |
| Urabe, T | 2 |
| Shimura, H | 1 |
| Onodera, M | 1 |
| Yoshimoto, T | 1 |
| Fujimoto, S | 1 |
| Muraki, M | 1 |
| Kobayashi, R | 1 |
| Yoshidumi, T | 1 |
| Yamauchi, T | 1 |
| Tokuda, K | 1 |
| Kaneko, S | 1 |
| Kai, Y | 1 |
| Sugiu, K | 1 |
| Fujinaka, T | 1 |
| Yoshimura, S | 1 |
| Hyogo, T | 1 |
| Kuwayama, N | 1 |
| Ahn, CM | 1 |
| Hong, SJ | 1 |
| Park, JH | 1 |
| Kim, JS | 1 |
| Lim, DS | 1 |
| Yamaguchi, M | 1 |
| Sasaki, M | 1 |
| Ohba, H | 1 |
| Mori, K | 1 |
| Narumi, S | 1 |
| Katsura, N | 1 |
| Ohura, K | 1 |
| Kudo, K | 1 |
| Terayama, Y | 1 |
| Kato, T | 1 |
| Sakai, H | 1 |
| Takagi, T | 1 |
| Nishimura, Y | 1 |
| Nighoghossian, N | 1 |
| Derex, L | 1 |
| Douek, P | 1 |
| Akaji, K | 1 |
| Tanizaki, Y | 1 |
| Hiraga, K | 1 |
| Akiyama, T | 1 |
| Dembo, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Deep Learning Model Based on Routine Ultrasound Scanning Video to Help Doctors Improve the Diagnosis of Carotid Plaque[NCT05230576] | 2,000 participants (Actual) | Observational | 2020-05-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cilostazol and Carotid Stenosis
| Article | Year |
|---|---|
Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting.
Topics: Angioplasty; Cardiovascular Agents; Carotid Stenosis; Chi-Square Distribution; Cilostazol; Humans; M | 2016 |
The vulnerable carotid artery plaque: current imaging methods and new perspectives.
Topics: Anticoagulants; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Cilostazol; Diag | 2005 |
5 trials available for cilostazol and Carotid Stenosis
| Article | Year |
|---|---|
Cilostazol reduces periprocedural hemodynamic depression in carotid artery stenting.
Topics: Aged; Angioplasty; Bradycardia; Carotid Stenosis; Cilostazol; Clopidogrel; Female; Humans; Hypotensi | 2013 |
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combinati | 2017 |
Cilostazol may suppress restenosis and new contralateral carotid artery stenosis after carotid endarterectomy.
Topics: Aged; Carotid Stenosis; Cilostazol; Endarterectomy, Carotid; Female; Humans; Male; Platelet Aggregat | 2010 |
Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Corona | 2011 |
Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting.
Topics: Aged; Aged, 80 and over; Blood Vessel Prosthesis; Carotid Stenosis; Cilostazol; Female; Fibrinolytic | 2012 |
14 other studies available for cilostazol and Carotid Stenosis
| Article | Year |
|---|---|
Cilostazol alleviates white matter degeneration caused by chronic cerebral hypoperfusion in mice: Implication of its mechanism from gene expression analysis.
Topics: Animals; Brain; Carotid Stenosis; Cell Differentiation; Cilostazol; Corpus Callosum; Gene Expression | 2018 |
Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model.
Topics: Animals; Aripiprazole; Brain; Brain Ischemia; Carotid Stenosis; Cilostazol; Cognition; Cognitive Dys | 2019 |
Cilostazol inhibits accumulation of triglycerides in a rat model of carotid artery ligation.
Topics: Animals; Cardiovascular Agents; Carotid Artery, Common; Carotid Stenosis; Cholesterol, HDL; Cilostaz | 2013 |
Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
Topics: Aged; Angioplasty; Aspirin; Brain Ischemia; Carotid Stenosis; Cilostazol; Clopidogrel; Diffusion Mag | 2014 |
Cilostazol inhibits leukocyte-endothelial cell interactions in murine microvessels after transient bilateral common carotid artery occlusion.
Topics: Animals; Carotid Stenosis; Cilostazol; Disease Models, Animal; Dose-Response Relationship, Drug; End | 2014 |
Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Carotid Stenosis; Cilostazol; Clopidogrel; Drug | 2014 |
Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions.
Topics: Aged; Aged, 80 and over; Angiography; Carotid Artery, Common; Carotid Stenosis; Cilostazol; Drug Adm | 2016 |
Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Dia | 2016 |
Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion.
Topics: Animals; Behavior, Animal; Brain Ischemia; Carotid Stenosis; Chronic Disease; Cilostazol; Cognition; | 2016 |
Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model.
Topics: Animals; Bacteria; Carotid Stenosis; Chronic Disease; Cilostazol; Corpus Striatum; Cyclic AMP Respon | 2009 |
Crucial role for Ser133-phosphorylated form of cyclic AMP-responsive element binding protein signaling in the differentiation and survival of neural progenitors under chronic cerebral hypoperfusion.
Topics: Animals; Apoptosis; Brain Ischemia; Carotid Stenosis; Cerebral Ventricles; Cerebrovascular Circulati | 2009 |
Periprocedural cilostazol treatment and restenosis after carotid artery stenting: the Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS).
Topics: Aged; Carotid Stenosis; Cilostazol; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Pl | 2012 |
Quantitative assessment of changes in carotid plaques during cilostazol administration using three-dimensional ultrasonography and non-gated magnetic resonance plaque imaging.
Topics: Aged; Carotid Stenosis; Cilostazol; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance I | 2012 |
[A case of carotid stenting via the transbrachial approach in the bovine arch].
Topics: Aged; Aspirin; Brachial Artery; Carotid Artery, Common; Carotid Artery, Internal; Carotid Stenosis; | 2006 |